Skip to main content

Table 1 Baseline characteristics

From: The protective effects of phosphodiesterase-5 inhibitor, sildenafil on post-resuscitation cardiac dysfunction of cardiac arrest: by regulating the miR-155-5p and miR-145-5p

  SHAM group (n = 8) SA group (n = 8) Sildenafil group (n = 8) Sildenafil + L-NANE group (n = 8)
Weight (kg) 29.13 ± 2.16 30.63 ± 0.92 30.38 ± 0.92 30.44 ± 0.89
HR 99.00 ± 7.44 101.38 ± 8.30 100.50 ± 10.04 101.52 ± 9.84
MAP, mmHg 103.12 ± 5.19 101.88 ± 5.22 99.00 ± 5.81 102.41 ± 5.21
MPAP, mmHg 23.42 ± 4.32 24.13 ± 5.24 24.34 ± 4.56 23.72 ± 4.68
CO, L/min 2.86 ± 0.22 2.99 ± 0.20 2.99 ± 0.19 2.89 ± 0.22
DO2, ml/min 444 ± 39 445 ± 34 450 ± 28 439 ± 31
VO2, ml/min 112 ± 12 112 ± 9 115 ± 12 113 ± 10
ERO2, % 24.17 ± 2.34 25.44 ± 2.70 25.46 ± 1.49 25.36 ± 1.76
Lac, mmol/L 1.21 ± 0.49 1.31 ± 0.72 1.23 ± 0.401 1.24 ± 0.42
  1. Values are mean ± SD or number (n)
  2. SHAM sham, SA saline, HR heart rate, CO cardiac output; MAP mean aortic pressure, MPAP mean pulmonary arterial pressure, DO2 oxygen delivery, VO2 oxygen consumption, ERO2 extraction of oxygen, Lac lactate